Clinical Trials Directory

Trials / Completed

CompletedNCT04442594

REMINISCENCES and EMOTIONS : Reminiscence Triggered by Virtual Reality for Older Adults With Mood Disorders

REMINISCENCES : Reminiscence Triggered by Virtual Reality for Older Adults With Mood Disorders

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Centre Hospitalier Universitaire de Nice · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers
Not accepted

Summary

Presentation \& Pre-screening of the control group / reminiscence group Patient/resident pre-screening team meeting for the study Explanation and proposal of the study to patients and their families Signature of resident/patient and family consents Audit of inclusion and non-inclusion criteria Inclusion Medical advice for VR Clinical interview with the family or legal guardian for an accurate life history + an anamnesis interview (psychologist or doctor) with the patient or resident. Creation of video contents Creation of personalized video contents Clinical scales review Evaluation of the number of psychotropic molecules prescribed (coordinating doctor, general practitioner, geriatrician) * Pre-test phase with the patient for the use of the VR headset * Randomisation * Session procedure As previously mentioned, the virtual reality sessions will take place in a quiet setting twice a week in the living or hosting residence. The sessions will be hold over a period of time of 6 weeks. Each subject of the reminiscence group will have two personalised virtual surroundings (after data being collected from team and/or families). The virtual environment will change every 3 weeks in order to avoid the phenomenon of habituation. The subjects of the control group will be exposed to two generic virtual settings (beach, mountain etc.) with a different virtual environment every 3 weeks. During the session, note will be taken on the subject's speech. The session will also be filmed and/or recorded with a prior signed agreement by the patient or his representative. \- Last session (S6) Review of clinical scales (re-testing) Re-evaluation of drug prescriptions

Conditions

Interventions

TypeNameDescription
PROCEDUREvirtual reality sessionThe virtual reality sessions will take place in a quiet setting twice a week in the living or hosting residence. The sessions will be hold over a period of time of 6 weeks. The virtual environment will change every 3 weeks in order to avoid the phenomenon of habituation.

Timeline

Start date
2020-12-02
Primary completion
2022-03-01
Completion
2023-02-01
First posted
2020-06-22
Last updated
2023-02-13

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04442594. Inclusion in this directory is not an endorsement.